Inovio Pharmaceuticals Inc (INO)

[Everywhereman]

Roche valued ONE pre clinical (animal studies) vaccine at 400 million Not Inovio. If that is worth 400 million it is easy to say that the HPV/cancer vaccine nearing the end of phase 2 is worth at least 2 times as much. Then you would value all of the Phase 1 trial vaccines at at least 50% more... You can easily compute a value at over 2 billion for the company based on that alone. That does not include the many other pre clinical drugs.....